Gracell Biotechnologies logo

Gracell Biotechnologies

A Member of the AstraZeneca Group

33 employees · est. 2017 · Shanghai, China

VS
SQZ Biotechnologies logo

SQZ Biotechnologies

Unlocking the full potential of cell therapies for patients around the world

18 employees · est. 2013 · Watertown, United States

SQZ Biotechnologies is the older company (2017 vs 2013).

Side-by-Side Comparison

Gracell Biotechnologies SQZ Biotechnologies
Founded
2017 2013 older
Headquarters
Shanghai, China Watertown, United States
Employees
33 18
Industry
Biotechnology, Health Care Biotechnology, Health and Wellness, Life Sciences
Funding Stage
Acquired Grant
Total Funding
$1.29B $229.81M
Funding Rounds
6 13
Services
Cell Therapy Development, Innovative CAR-T Technologies, Next-Generation Therapeutic Solutions Not tracked yet
Target Customers
Cancer Patients, Patients with Autoimmune Diseases, Medical Institutions Seeking Advanced Therapies, Healthcare Providers Not tracked yet
Taxonomy
Biopharmaceuticals, Clinical-stage, Cell Therapy, Autologous Therapy, Allogeneic Therapy, Cancer Treatment, Autoimmune Diseases, Hematological Malignancies, Solid Tumors, FasTCAR Technology, TruUCAR Technology, SMART CART Technology, R&D, Cellular Therapeutics, Immunotherapy Cell Therapies, Clinical-stage, Immune Tolerance, Solid Tumors, Autoimmune Diseases, Immune Responses, Cell Squeeze® Technology, Patient Experience, Therapeutics, Cancer, Infectious Diseases, Immune Reactions, Accelerated Production, Immune Therapy
Website
gracellbio.com sqzbiotech.com
Gracell Biotechnologies logo

About Gracell Biotechnologies

Gracell Biotechnologies, a prominent player within the biopharmaceutical sector, stands as a global clinical-stage company under the esteemed umbrella of the AstraZeneca Group. Founded in 2017 and headquartered in China, Gracell is at the forefront of pioneering cutting-edge solutions for cancer and...

SQZ Biotechnologies logo

About SQZ Biotechnologies

SQZ Biotechnologies is a clinical-stage biotechnology company with a focus on leveraging its proprietary Cell Squeeze® technology to revolutionize cell therapies for patients with cancer, autoimmune, and infectious diseases. The company aims to develop well-tolerated cell therapies that offer therap...

We will tell you when either one moves

BounceWatch watches Gracell Biotechnologies and SQZ Biotechnologies for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Gracell Biotechnologie... and SQZ Biotechnologies — by email.

Frequently Asked Questions

Gracell Biotechnologies — A Member of the AstraZeneca Group. SQZ Biotechnologies — Unlocking the full potential of cell therapies for patients around the world. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Gracell Biotechnologies has raised $1.29B while SQZ Biotechnologies has raised $229.81M.
Gracell Biotechnologies and SQZ Biotechnologies operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Gracell Biotechnologies with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Gracell Biotechnologies on 23 Jun 2026, and SQZ Biotechnologies on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes